Literature DB >> 20581393

mTOR inhibitors in polycystic kidney disease.

Terry Watnick, Gregory G Germino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20581393     DOI： 10.1056/NEJMe1006925

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  35 in total

1.  A portable fiberoptic ratiometric fluorescence analyzer provides rapid point-of-care determination of glomerular filtration rate in large animals.

Authors:  Exing Wang; Daniel J Meier; Ruben M Sandoval; Vanessa E Von Hendy-Willson; Barrak M Pressler; Robert M Bunch; Mouhamad Alloosh; Michael S Sturek; George J Schwartz; Bruce A Molitoris
Journal:  Kidney Int       Date:  2011-08-31       Impact factor: 10.612

Review 2.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

3.  The Gretchen question in autosomal-dominant polycystic kidney disease research.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2011-03       Impact factor: 4.599

4.  Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.

Authors:  Alan S L Yu; Chengli Shen; Douglas P Landsittel; Jared J Grantham; Larry T Cook; Vicente E Torres; Arlene B Chapman; Kyongtae Ty Bae; Michal Mrug; Peter C Harris; Frederic F Rahbari-Oskoui; Tiange Shi; William M Bennett
Journal:  Kidney Int       Date:  2019-03-04       Impact factor: 10.612

Review 5.  Kidney: polycystic kidney disease.

Authors:  Binu M Paul; Gregory B Vanden Heuvel
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-09-03       Impact factor: 5.814

6.  Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice.

Authors:  Ao Li; Xin Tian; Xiaoli Zhang; Shunwei Huang; Yujie Ma; Dianqing Wu; Gilbert Moeckel; Stefan Somlo; Guanqing Wu
Journal:  Am J Pathol       Date:  2015-10       Impact factor: 4.307

7.  Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; James E Bost; Vicente E Torres; Lisa Guay-Woodford; Kyongtae Ty Bae; Douglas Landsittel; Jie Li; Bernard F King; Diego Martin; Louis H Wetzel; Mark E Lockhart; Peter C Harris; Marva Moxey-Mims; Mike Flessner; William M Bennett; Jared J Grantham
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 8.237

8.  Effect of dimethyl fumarate on renal disease progression in a genetic ortholog of nephronophthisis.

Authors:  Oliver Oey; Padmashree Rao; Magdalena Luciuk; Carly Mannix; Natasha M Rogers; Priyanka Sagar; Annette Wong; Gopala Rangan
Journal:  Exp Biol Med (Maywood)       Date:  2018-02-13

9.  Polycystin-1 and Gα12 regulate the cleavage of E-cadherin in kidney epithelial cells.

Authors:  Jen X Xu; Tzong-Shi Lu; Suyan Li; Yong Wu; Lai Ding; Bradley M Denker; Joseph V Bonventre; Tianqing Kong
Journal:  Physiol Genomics       Date:  2014-12-09       Impact factor: 3.107

10.  Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin.

Authors:  Djalila Mekahli; Jean-Paul Decuypere; Eva Sammels; Kirsten Welkenhuyzen; Joost Schoeber; Marie-Pierre Audrezet; Anniek Corvelyn; Georges Dechênes; Albert C M Ong; Martijn J Wilmer; Lambertus van den Heuvel; Geert Bultynck; Jan B Parys; Ludwig Missiaen; Elena Levtchenko; Humbert De Smedt
Journal:  Pflugers Arch       Date:  2013-11-06       Impact factor: 3.657
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.